Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Urinary incontinence, or leakage of urine, is a very common condition for women of all ages, ethnicities and backgrounds.

A football fan who has stage four prostate cancer is backing a campaign for sanitary bins to be put in men's toilets at ...

WHEN was the last time you thought about your pelvic floor? Maybe never? If so, it’s time to start paying some attention as ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Driven by a combination of demographic, social, and technological factors, the disposable incontinence products industry is ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Are you looking for a new way to spice up your porn experience? Check out these sexy Aussie gay male OnlyFans creators! These creators offer exclusive content that will keep you entertained for hours.

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...